Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim launches 'gamified' COPD initiative

Programme aims to encourage and reward disease management
Boehringer Ingelheim

Boehringer Ingelhiem has launched a gamified support programme to help people living with chronic obstructive pulmonary disease (COPD) manage their disease.

The company says the free, online programme, for which it has partnered with HealthPrize, is a first for pharma as it seeks to offer follow-up services for patients prescribed its Spiriva Respimat treatment.

The RespiPoints programme encourages patients to meet treatment goals by reporting on taking medication, verifying their monthly refills and reading educational materials on COPD.

Points can be earned by completing each of these tasks - as well as taking part in quizzes and surveys on the site - which are redeemable as e-gift cards.

Boehringer Ingelheim hopes the programme will improve the currently poor adherence to treatment plans that is common among people with COPD, often resulting in increased adverse symptoms, healthcare costs and hospitalisation.

Ruchin Kansal, business innovation lead at Boehringer, said that the company is “proud to continue our unwavering commitment to the COPD community with new technology and support services that can help improve patient outcomes”.

“The RespiPoints programme is the latest in a series of efforts to empower people living with COPD to better manage their health with tools that are engaging and educational,” he added.

Boehringer Ingelheim recently signed a digital health deal with Propeller Health to help track how patients use inhaled medications.

The digital platform will utilise apps, analytics, educational materials and feedback to gather data on adherence rates and so gain a greater understanding of patient engagement with COPD treatment.

Article by
Rebecca Clifford

16th June 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...